Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Endothelial dysfunction markers in cervical cancer and their influence on patient outcome.

Molecular biology reports - 13 Jan 2026

Raeck Juliane, da Silva José Brito, Carvalho Luísa, Salgado Lurdes, Pereira Deolinda, Neto Beatriz Vieira, Tavares Valéria, de Melo Inês Guerra, Medeiros Rui

Abstract excerpt

BACKGROUND: Cervical cancer (CC) is a major cause of cancer-related mortality worldwide. Among CC patients, venous thromboembolism (VTE) represents the second leading cause of death, surpassed only by the malignancy itself. This life-threatening condition is characterised by blood stasis, heightened tendency for blood clotting (blood hypercoagulability), and endothelial dysfunction (ED). Single-nucleotide...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Endothelium, Vascular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Nitric Oxide Synthase Type III

Share to Polymorphism, Single Nucleotide

Share to Prognosis

Share to Uterine Cervical Neoplasms

Share to Venous Thromboembolism

Source

Open in PubMed Open full text

Identifiers

PMID: 41528397
DOI: 10.1007/s11033-026-11448-z
PMCID: PMC12799642

Genes

NOS3
SELP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Endothelial dysfunction markers in cervical cancer and their influence on patient outcome.PMID 41528397Read ↗

Endothelial Dysfunction Markers in Cervical Cancer and their Influence on Patient OutcomeSemantic proximity Read ↗

Endothelial Dysfunction Markers in Ovarian Cancer: VTE Risk and Tumour Prognostic OutcomesSemantic proximity Read ↗

Haemostatic gene variations in cervical cancer-associated venous thrombosis: considerations for clinical strategies.Semantic proximity Read ↗

Thrombogenesis-associated genetic determinants as predictors of thromboembolism and prognosis in cervical cancer.Semantic proximity Read ↗

Implications of venous thromboembolism GWAS reported genetic makeup in the clinical outcome of ovarian cancer patients.Semantic proximity Read ↗

Venous thromboembolism GWAS reported genetic makeup and the hallmarks of cancer: Linkage to ovarian tumour behaviour.Semantic proximity Read ↗

Cancer genetic profile and risk of thrombosis.Semantic proximity Read ↗

Reassessing HPSE in Ovarian Cancer: Beneficial After All?Semantic proximity Read ↗

Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer.Semantic proximity Read ↗

Relationship of common vascular endothelial growth factor polymorphisms and haplotypes with the risk of cervical cancer in Tunisians.Semantic proximity Read ↗

Polymorphisms of the coagulation system and risk of cancer.Semantic proximity Read ↗

Plasma microRNA Environment Linked to Tissue Factor Pathway and Cancer-Associated Thrombosis: Prognostic Significance in Ovarian CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.